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The main theories on population aging based on recent data on human longevity, life expectancy, morbidity
changes, disability trends, and mortality decrease are presented and discussed within their own geographic,
cultural, socioeconomic, and medical contexts. The complex interactions between all these components do not
facilitate trend forecasting of aging population (healthy aging versus disability pandemic). In the context of
population aging, four elements were introduced with their implications: 1) an increase in the survival rates of
sick persons, which would explain the expansion of morbidity, 2) a control of the progression of chronic diseases,
which would explain a subtle equilibrium between the decrease in mortality and the increase in disability, 3) an
improvement of the health status and health behaviors of new cohorts of elderly people, which would explain the
compression of morbidity, and eventually 4) an emergence of very old and frail populations, which would explain
a new expansion of morbidity. Obviously, all these elements coexist today, and future trend scenarios—expansion
or compression of disability—depend on their respective weights leading to the need of elaborating ‘‘a general
theory on population aging.’’ This theory has to be based on a world harmonization of functional decline
measurements and a periodic ‘‘International Aging Survey’’ to monitor global aging through a sample of carefully
selected countries.
RECENTLY, Freedman and colleagues publisheda systematic review of disability trends among older
adults in the United States during the late 1980s and 1990s,
showing consistent evidence of decline in physical
functional limitations (difficulty lifting and carrying a bag
of roughly 10 pounds, climbing stairs, and walking a quarter
of mile) and conflicting evidence of decline in basic
activities of daily living (ADL) disability (i.e., bathing,
mobility, toileting, dressing, transfer from bed to chair,
feeding) (1).
At the same time, Robine and colleagues collected
evidence that ADL disability is clearly declining among
the older people in Europe (2), especially in the United
Kingdom, where the decrease in the inability to carry out
ADLs was substantial over the period from 1976 to
1994 (3).
The lack of consensus on trends in personal care disability
between the United States and Europe is disturbing all the
more now that developing countries, such as Taiwan, today
experience opposite trends in physical functional limitations
(4). These apparently contradictory trends in functioning
and disability, which were at the origin of numerous and
interesting health theories (5–10), require a newer and wider
conceptual framework, which will be first justified and then
developed in the present article. The need of a general
framework to organize the numerous findings related to
aging has been recently underlined by others, but this was
related more to mortality and longevity without great
consideration for the population health status (11,12).
MODELS, THEORIES, AND DATA ON THE EVOLUTION OF
POPULATION HEALTH STATUS
From Demographic Transition to
Compression of Morbidity
The present sustained increase in life expectancy at birth
in low-mortality countries (13,14) is no longer a surprise, as
was the case a few years ago. From now on, the continuation
of the increase in life expectancy at birth is due to the
mortality decline at the highest ages (15), even if the exact
causes of this fall in the oldest-old mortality rate are not yet
clarified. Moreover, nobody knows what will be the future
consequences in terms of age structure or in terms of health
status of the population.
All conceptual health population models dated back to the
1970s–1980s or even earlier, namely the demographic
transition (5), the epidemiological transition (6), and the
rectangularization of the survival curve and the compression
of morbidity (9). In fact, these models shared the same
framework: a) before the transition, mortality and fecundity
were high, causes of deaths were linked to infectious
diseases or accidental trauma, and the population was
young, and b) after the transition, mortality and fecundity
were lower but stable, and causes of deaths were
degenerative or aging related. The population was old but
the life expectancy was limited to 85 years with a small
dispersion of individual life spans around this mean value.
This limited life expectancy associated with the control of
the risk factors (morbidity) would explain a rectangular
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survival curve for the whole population (called compression
of morbidity) (9).
In this framework, the probabilities of survival above age
90 were low and little attention was given to changes in age
structure or to changes in functional health status.
Empirical Evidence and Alternative Scenarios
In Switzerland, for instance:
 At the beginning of the 1970s, life expectancy at birth
was 70.1 years for men and 76.2 years for women; 5.1%
of men and 11.3% of women survived to age 90 in the
mortality conditions of 1968–1973.
 20 years later, in 1990, life expectancy at birth was 74.0
years for men and 80.8 years for women; 10.1% of men
and 25.1% of women survived to age 90 in the mortality
conditions of 1988–1993.
 In 2001, life expectancy at birth was 77.2 years for men
and 82.8 for women (16).
 In Japan, in 2001, life expectancy at birth reached 78.1
years for men and 84.9 years for women, 18.2% of men
and 40.1% of women survived to age 90 in the mortality
conditions of 2001 (17).
When it was realized in the 1980s that mortality was
falling at old ages, the initial thought was linked to medical
care progress allowing a longer survival. One then feared
a pandemic of chronic diseases and disabilities (8,18–21).
For example, Fuchs wondered whether people escaped
death from heart disease only to live in poor health (22).
Manton opposed the fears of Gruenberg and Kramer to the
optimism of Fries and proposed an alternative scenario in
which the increased prevalence of chronic diseases was
counterbalanced by a decrease in the severity of the same
diseases (10). Following Manton, scholars built a conceptual
framework with three main possibilities when mortality
decreases among the old people:
1. An expansion of morbidity (chronic diseases and
disability),
2. A dynamic equilibrium (between prevalence and sever-
ity),
3. A compression of morbidity (23–25).
A New Measure: The Healthy Active Life
Expectancy (HALE)
As early as 1984, the World Health Organization (WHO)
proposed a general model of health transition making
possible the evaluation of the consequences of the increase
in survival on health status. This model, which consisted of
an extension of the notion of life expectancy to morbidity
and disability, made possible the calculation of not only
life expectancy, but also disease-free life expectancy
and disability-free life expectancy (26). The constitution of
chronological series on the prevalence of chronic diseases
and disability in the population and the calculation of
‘‘healthy active life expectancies’’ provided the ability to
monitor the consequences of the decrease in mortality among
the oldest-old. These chronological series helped WHO
experts to identify four different possible scenarios:
1. ‘‘A rectangularization of the survival curve,’’ followed
by a compression of morbidity and disability at the
late ages of life, corresponding to Fries’ theory (9), the
disease-free and disability-free curves drawing nearer to
the total survival curve;
2. ‘‘A pandemic of chronic diseases and disabilities,’’ cor-
responding to Gruenberg’s and Kramer’s theories (18,19),
which would exclusively concern total survival;
3. ‘‘A lengthening of the biological life duration,’’ cor-
responding to Strehler’s theories (7), with a parallel shift
of the three curves towards the right, illustrating a vast
change in biological aging;
4. Finally, the case of relative independence in the evolu-
tion of the three curves, the interventions being liable,
for example, to postpone the onset of diseases or reduce
their disabling consequences.
This general model of health transitions was appealing,
and, since its publication, many calculations have been
carried out. Figure 1 shows an example of its application in
France, where the increase in life expectancy during the
period 1981–1991 was accompanied by a parallel increase
in disability-free life expectancy while life expectancy
without chronic diseases remained constant (see Figure 1).
This apparent contradiction in the changes in disability and
morbidity provided an example of the theory of dynamic
equilibrium proposed by Manton in 1982. With the decline
in mortality, the prevalence of reported chronic diseases
increased but these diseases were on average less severe and
induced less disability (27).
REVES: The International Network on
Health Expectancy
In this context and a few years later, an International
Network on Health Expectancy and the Disability Process
(http://www.prw.le.ac.uk/reves/) (the French acronym for
which was REVES [Re´seau d’Espe´rance de Vie en Sante´])
was created to facilitate international collaboration in health
expectancy calculations (2). Today, calculations are made
for more than 50 countries and times series available in
almost all low-mortality countries, in Europe (28), in North
America (29), in Asia (30), or in Australia and New Zealand
(31). The gathered calculations cover a 40-year period, from
1958 to 1998, and can be used to compare changes in life
expectancy, disease free-life expectancy and disability free-
life expectancy (all levels of disability combined), and
‘‘severe’’ disability free-life expectancy.
All together, these multiple, repeated, and harmonized
calculations showed: a) a universal and regular increase in
life expectancy at age 65 in the low-mortality countries
since 1970; b) the same was not true for disability free-life
expectancy, which appeared to stagnate. The gains in life
expectancy might be years with disability (whatever the
disability level); c) On the other hand, ‘‘severe’’ disability-
free life expectancy evolved in parallel with life expectancy
in all the countries in which data were available, namely,
Australia , Canada, France, Japan, the United Kingdom, and
the United States. This probably meant that if the years
gained in life expectancy were years of life with disability,
they were not with severe disability (32).
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The analysis of time series of disability-free life ex-
pectancy by severity level in comparison with trends in
total life expectancy and life expectancy without disabling
chronic or longstanding disease again supported the ‘‘theory
of dynamic equilibrium,’’ which partly explained the in-
crease in life expectancy by a slowing down in the rate of
progression of chronic diseases (10).
In the low-mortality countries, the decline in mortality
among the oldest-old during the 1980s and 1990s was
accompanied by an increase in the reported prevalence of
chronic diseases and perhaps by an increase in the total
prevalence of reported disability. But these diseases were on
average less severe and led less often to severe levels of
reported disability. The results indicate that, at worst, the
increase in life expectancy is accompanied by a pandemic of
light and moderate but not of severe disabilities (2).
Contradictory Trends in Disability and Functioning
In addition to these general results based on the notion of
severity for disability, many studies relate to time series on
the prevalence of various health conditions. Although some
results are convergent, others are contradictory.
It clearly appeared that the reported prevalence of chronic
diseases increased in low-mortality countries such as
England (33), Finland (34), France, or the Netherlands.
But these diseases were less often associated with reported
disability (35–37). However, when one moved from reported
diseases to reported functional limitations or reported dis-
ability, there was no longer convergence of the results.
Functional limitations.—In the United States, physical
functional limitations among older people (difficulty lifting
and carrying a bag of roughly 10 pounds, climbing stairs,
and walking a quarter of a mile) decreased significantly in
the 1980s and 1990s (37–39), suggesting an improvement in
physical vigor. Similar results were found in the French
Paquid survey with the items ‘‘climbing stairs and walking
500–1000 meters’’ for the period 1988–1998 and the 75–84-
year age group (40).
However, the opposite was observed for ‘‘problems
climbing stairs’’ during the period 1981–1992 in New
Zealand (3), for ‘‘seeing, hearing, and walking difficulties’’
during the period 1986–1998 in Quebec, Canada (41), or
for ‘‘climbing and walking difficulties’’ during the period
1993–1999 in Taiwan (4). Moreover, disabling conditions
and impairments (loss of sight, loss of hearing, incomplete
use of arms or fingers, incomplete use of legs or feet, need
for help, or supervision because of a mental illness or con-
dition increased significantly during the period 1981–1998
in Australia (31). [For the most recent period, 1993–1998,
‘‘severe’’ disability-free life expectancy decreased in
Australia (31)]. In Great Britain, the prevalence of several
functional limitations reported in the 1996–1997 survey was
much higher than in the earlier 1985 survey (42).
Finally, no change in physical functional limitations was
found for the 55–84-year age group during the period 1992–
1998 in the Netherlands (43), as well as no change in the
level of blindness or hearing impairments among older
Americans between 1984 and 1995 (44).
Mild disability and instrumental activities of daily living
(IADL) difficulties.—Only France and the United States
seemed to reveal a clear decline in physical functional
limitations among older people and a significant decline in
mild disability measured through activity restriction in daily
Figure 1. Survival without disease and survival without disability (World Health Organization model, 1984), France, 1981–1991, females.
592 ROBINE AND MICHEL
life, such as ‘‘hampered in the daily life’’ in France and IADL
restrictions in United States. In France, the decline in
disability observed during the period 1981–1991 (45) was
confirmed with the Paquid cohort for the 1988–1998 period.
Independence significantly improved among the 75–84-
year-olds, thanks to a decline in mild disability for men
and in ADL and IADL problems for women (40). In the
United States, researchers found a consistent decline in
IADL disability at age 65 years and older (46–53). In both
countries, trends toward more educated elderly cohorts could
partially explain the disability decline (39,54), although
other explanations can be entertained (55,56). These trends
could also be explained by an improvement in cognitive
functioning (57,58). Furthermore, in both countries, decline
in institutional use was observed (52,59). However, if a clear
decline in institutional use before the age of 90 years was
observed in France, the rate of institutionalization among
those aged 90 years and older has significantly increased
since 1975 due to the aging of this open-end age group (59);
in the United States, the smaller proportion of persons living
in a nursing home had greater disability in 1997 compared
with 1985 (60). It is quite possible that Finland offered a third
example of clear decline in disability since the 1980s (61).
But in other countries such as Australia, Canada, Great
Britain, and the Netherlands, mild disability seemed to be
increasing.
Severe disability/ADL difficulties.—Severe disability,
measured through ADL difficulties or bedridden and home
confinement, appeared to decline in the United Kingdom,
Finland, Switzerland, and France. Decrease in ADL
disability among older persons was observed in the United
Kingdom during the 1976–1994 period (3), in Finland
during the 1986–1994 period (34), in Switzerland during the
1979–1994 period (62), and in France for women during
the 1988–1998 period (40). Severe disability appeared to
stagnate in the United States and the Netherlands. In the
United States, for persons aged 70 and older, most of the
decline in disability involved routine activity needs (IADLs)
but not personal care needs (ADLs) (49,53,63). In the
Netherlands, there was no trend in severe disability (43).
Severe disability has increased in Australia and perhaps in
Japan. In Australia, severe disability substantially increased
during the period 1993–1998, and in Japan, the inability
to perform at least one ADL increased from 1992 to
1998 (64).
Perceived health.—It is now acknowledged that perceived
health can follow a separate trend from disability (65,66). It
was especially feared or expected that perceived health
would deteriorate even if functional status improved.
However, several recent studies showed an improvement
in perceived health of older people (34,62). In Austria, for
example, life expectancy in good perceived health at age 65
increased for women from 3.5 years in 1978 to 8.3 years in
1998 (67) (based on the health ratings ‘‘very good’’ and
‘‘good’’).
Synthesis and interpretative attempts.—In the United
States, several authors tried to produce meaningful synthesis
from these various data and trends (20,48,63,65) and
explored the possibility of a turning point in the 1980s
(49,68). In 2002, Freedman and colleagues (58) published
a systematic review of disability trends among the older
adults during the late 1980s and 1990s, showing consistent
evidence of decline in any disability, IADL disability and
physical functional limitations, limited evidence of decline
in cognitive functional limitation, and conflicting evidence
of decline in basic ADL disability.
Several authors wondered whether opposite trends could
correspond to different phases of the epidemiological
transition. Robine, for example, wondered whether a general
theory would make it possible to reconcile the various
theories on the evolution of health status—‘‘pandemic
of disabilities,’’ ‘‘dynamic equilibrium,’’ and ‘‘morbidity
compression’’—which would only be the different stages
of a single transition (24). Zimmer and colleagues tried to
reconcile American and Taiwanese results on physical
functional limitations by wondering again whether the ex-
pansion and compression of morbidity scenarios would
be both correct but corresponding to different stages of the
same transition (4). A recent study in the United States
showed, by utilizing disability-free life expectancy calcu-
lations from 1970 to 1990, that compression of morbidity
began among those of higher educational status, whereas
those of lower status were still experiencing expansion of
morbidity (69) underlining again the need of a general theory
on population aging and disability transition.
TOWARD A GENERAL THEORY ON POPULATION AGING
Of course, several authors sought to improve the existing
models of transition either by integrating new dimensions
such as disability (70) or by adding a new stage into the fall
of mortality—a fourth stage, such as the ‘‘Age of Delayed
Degenerative Diseases’’ (71). But none of them basically
reconsidered the demographic transition to fully account for
population aging, which accompanied the various observed
demoepidemiological changes. Such a general theory of
population aging during the transition would deserve to
cover at least 2 domains: 1) age structure modification over
time including the emergence of new segments of the pop-
ulation such as the nonagenarians and centenarians, and 2)
change in the functional health of the whole population.
Age Structure and Transition
The changes in age structure that accompany the various
phases of demographic transition are often paradoxical and,
for that reason, poorly understood. Thus, one knows or at
least one should know that a decrease in mortality rejuvenates
the population at the beginning of the transition. In the same
way, population aging, in particular accelerated aging, so
frequent in many developing countries does not inevitably
increase the number of old people, at least at the beginning.
 In fact, during the demoepidemiological transition, the fall
of mortality initially related to infant mortality inflated the
number and the proportion of children with the conse-
quence that there was a rejuvenation of the population.
 The fall of fertility, started in reaction to the surge of
young people, immediately decreased the number and the
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proportion of children, whereas the number and the
proportion of young adults swelled, leading to an increase
of the mean age of the population.
 If the fall of mortality and fertility were simultaneous and
quantitatively similar, the population would have known
an accelerated rejuvenation followed by accelerated aging
(at least 40 years are always needed for young adults to
become old people). This time lag between the beginning
of aging and the appearance of old people, especially
visible in developing countries, is better identified by
demographers and economists who used to speak of
a demographic ‘‘gift’’ or ‘‘bonus,’’ ‘‘golden age,’’ or
‘‘window of opportunity’’ (72–74). Nowadays in the low-
mortality countries (e.g., the most advanced in the
transition), the fall of mortality immediately ages the pop-
ulation by directly increasing the number and the
proportion of the oldest-old.
This general movement of transition, corresponding to
a successive growth in the numbers of various age groups,
initially children and teenagers, then young adults, and
finally old people, led to the emergence of new segments of
the population. Indeed, when the phase of growth reaches
the last age group (the oldest-old), not only their numbers
but also their life span increase. Thus, centenarians,
exceptional until the end of the 19th century and rare until
the end of World War II, become plethoric today (75). Their
numbers have doubled approximately every 10 years since
1950 (76). People reaching the age of 105 years are
increasingly frequent in the low-mortality countries such as
Japan (77), and the maximum ages reported at death do not
cease to increase (78). One hundred ten years of age is no
longer an impassable limit (79).
The Disability Transition
Under such conditions, studying aging, health, and func-
tioning changes of populations becomes central. The ques-
tion does not concern the cause-of-death pattern changes,
which were the basis of the epidemiological transition. The
question now concerns the changes in the functional status
pattern of the survivors that constitute the functional or
‘‘disability transition.’’
This question was first studied by Myers and colleagues
(70,80). They developed 9 theories describing the disability
transition. The main idea was included in the first one:
‘‘Overall, crude rates of disability incidence are higher in the
initial stages of an epidemiological transition and prevalence
levels are lower. As the transition proceeds, a reversal
in these levels occurs.’’ With increased survival, the
authors considered that the likelihood of comorbidities for
an individual increases, thus leading to greater prevalence
levels of disabilities. Theory 8 underlined that, in addition,
reported prevalence might increase as individuals develop
higher expectations of functional health. To that end, theory
9 underlined that the proportion of disability-free life
expectancy was expected to decline during the transition.
In fact, several studies showed that the prevalence
of disability was much lower in high-mortality countries,
lending support to the first proposition. This is illustrated in
a spectacular way by the comparison of the levels of
disabilities of the Chinese and Danish centenarians; The
level of reported disability was much lower in China than in
Denmark (81). In Taiwan, at age 65 and older, difficulties in
walking and climbing stairs increased between 1993 and
1999 contrary to what was observed in the United States (4),
suggesting again that disability trends can be related to the
different stages of the epidemiological transition. However,
the published data do not allow comparison of the level
in functional limitations in both countries. But the general
idea is that at the beginning of the fourth stage of the
epidemiological transition, the ‘‘Age of Delayed Degener-
ative Diseases’’ proposed by Olshansky and Ault (71),
the fall of mortality concerns more the old or sick people
having functional limitation and consequently increases the
prevalence of disability among the population. This is the
hypothesis behind the morbidity expansion scenario pro-
posed in the 1980s by Gruenberg (8) and Kramer (19). Can
we imagine that Taiwan is experiencing this scenario today
whereas the United States is experiencing a compression of
morbidity?
Disability Versus Longevity
Since the publication of the theory of compression of
morbidity (9), vigorous discussions have been continuing
on the possibility of obtaining a compression of morbidity
at the end of the life span, due to a postponement of
the functional decline, which would not involve in turn
an increase in longevity. Recent studies suggested that
improvement in health behaviors, such as better nutrition,
smoking reduction, or increase in physical activities, would
reduce morbidity more than increase longevity (82–86).
Thus, if future increases in life expectancy are due to better
behaviors, they could also be accompanied by larger
increases in disability-free life expectancy leading to a
compression of disability. Only provision of time series of
both life expectancy and health expectancies will make it
possible to answer the questions raised since the 1980s.
Outside the United States, long chronological studies are
available for three countries: in Austria since 1978 with 4
points (67), in Great Britain since 1981 with 17 points
(33,87), and in Australia since 1981 also with 4 points (31)
(two other studies should soon be available in Denmark,
since 1987, and in the Netherlands, since 1989). In these
three countries:
 Female life expectancy at age 65 clearly increased in the
1980s and 1990s (in Austria, from 15.2 years in 1978 to
17.5 years in 1998; in Great Britain, from 16.9 years in
1991 for women to 19.8 years in 1999; and in Australia,
from 18.1 years in 1981 to 19.8 years in 1998.
 Female disability-free life expectancy (various long-
standing health problems) at age 65 varied greatly and
in opposing ways: in Great Britain, it increased from 8.5
years in 1981 to 9.5 years in 1999; in Australia, it
decreased from 10.0 years in 1981 to 9.0 years in 1998.
 Female life expectancy in good perceived health (‘‘good’’
and ‘‘very good’’ together) increased both in Great Britain
and Austria but much more strongly in Austria, from 3.5
years at age 65 for women in 1978 to 8.3 in 1998
(31,33,67,87).
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Consequently, the proportion of years lived in good
health decreased in Australia, remained constant in Great
Britain, and increased in Austria. It is noteworthy that life
expectancy at age 65 is initially higher in Australia, in
between in Great Britain, and lower in Austria. Similar
results are found for men. Overall, the comparison of these
three chronological series shows that health expectancies are
not evolving parallel to life expectancy, and it discloses
different national patterns. Each study supports one possible
scenario, expansion of morbidity in Australia between 1981
and 1998, dynamic equilibrium in Great Britain between
1981 and 1999, and compression of morbidity in Austria
between 1978 and 1998. The comparison suggests a possible
relationship between the initial value of life expectancy at
age 65 and change in health expectancies. It suggests that
expansion of disability goes with the highest life expectancy
and compression of morbidity with the lowest.
A general theory of population aging, including the
disability transition, should clearly take into account not
only the decrease in mortality and the potential increase or
decrease in disability, but also the initial levels of mortality
and disability, pinpointing where the countries are in the
transition stage. Only calculations of life and health ex-
pectancies provide all these elements. Their repetition at
regular intervals allows correct assessments of changes over
time. But today, they are very few and are using different
morbidity or disability indicators, which prevents direct
comparisons between countries and joint analysis.
At the oldest ages, from now on, frailty is added to
functional decline and comorbidity. Frailty is a biologic
syndrome of decreased physiological reserves and resistance
to stressors causing vulnerability to adverse outcomes, inde-
pendently of disability or comorbidity (88). The exhaustion
of reserve, seen as redundancy, can explain late-life mortality
deceleration (12,89). At these limits, frail persons cease to
be able to resist environmental hazards or resist extremely
weakly (90), which could explain the mortality plateaus
observed today at age 110 and older (79). In the same way,
a general theory on population aging should integrate
the emergence of the new segments of the population such
as the nonagenarians and centenarians. Moreover, this
general theory might explain the emergence of the frail
population.
A Draft Proposal
In the first phase of the epidemiological transition,
described by Omran in 1971 (6), modern economic devel-
opments resulted in a decrease in infant mortality due to
increased food availability, decline in infectious diseases,
and improvement of hygiene. All this progress initiated an
important decrease in infant mortality (since one did not
finally need large living improvements to obtain this infant
mortality reduction). A greater number of newborns then
carried out a ‘‘normal’’ life (91).
In the second phase, modern economic developments
contributed to a lengthening of the ‘‘normal’’ life duration
by reducing the mortality of older people. The fall of
mortality among older people, which started shortly after
WWII in the low-mortality countries (92), often raises
very disturbing and interesting questions. Generally, it
is explained by the considerable improvement in living
conditions that elderly people discovered after WWII,
including health and medical services availability. When
older peoples’ mortality started decreasing under the impact
of economic, medical, and technical progress, it initially
concerned a population in bad health in comparison with the
current population of the same age. The fall of mortality
then increased the prevalence of chronic diseases and
disability by at first increasing the survival rates of sick
persons. From that point on, sick persons had greater
chances of survival. It is the scenario of morbidity ex-
pansion that could have occurred in the United States in
the 1960s or 1970s (8) and which perhaps currently occurs
in Taiwan (4). Gradually, medical progress could slow
down the progression of chronic diseases involving
a kind of equilibrium with mortality decline (10). It is the
cardiovascular revolution (93) that could explain the turning
points in disability trends that some researchers believed had
been detected in the United States in the 1980s (49,68).
Progressively with the arrival of new cohorts, the health of
the elderly population continues to improve. Many argu-
ments go in this direction: a better adult life, a better educa-
tional level (54), and better health practices (55,56,94).
All could lead to a compression of morbidity phase, which
Austria, France, and the United States know today (1,85).
However, progress continues, particularly in the improved
environment and services provided to the oldest-old.
The fall of mortality leads from this point on to the emer-
gence of extremely old populations like that of the super-
centenarians and to the emergence of frail populations.
These new phenomena could bring us back to the starting
point, that is, to an expansion of morbidity. Would this be
the scenario that Australia currently knows (31)?
TEMPORARY CONCLUSION
Into this necessarily simplistic picture of population
aging, we successively introduced four elements:
1. An increase in the survival rates of sick persons, which
would explain the expansion of morbidity,
2. A control of the progression of chronic diseases, which
would explain a subtle equilibrium between the fall of
mortality and the increase in disability,
3. An improvement in health status and health behaviors of
the new cohorts of old people, which would explain the
compression of morbidity, and
4. An eventual emergence of the very old and frail
populations, which would explain a new expansion of
morbidity.
Obviously, all these elements coexist today and future
scenarios, expansion or compression of disability, depend
on their respective weights and lead to the need of
elaborating a new general theory on population aging.
PROPOSAL TO FACILITATE WRITING A
DEFINITE CONCLUSION
To move ahead, two avenues can be proposed:
1. The first consists of setting up universal measurements of
the functional decline, which one can combine with
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mortality data through time and all over the world. The
need for such harmonization is so obvious that the G8
claimed it since its Denver Summit in 1997.
2. The second would consist of setting up a periodic Inter-
national Aging Survey to monitor global aging through
a sample of carefully selected countries. This second
proposal can constitute an enthralling challenge for the
gerontological community.
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